Why Vetter’s Saarlouis expansion matters for sterile injectable supply chains

Injectable capacity is tightening. Vetter’s Saarlouis bet shows why Europe wants more control over sterile drug manufacturing.

Injectable capacity is tightening. Vetter’s Saarlouis bet shows why Europe wants more control over sterile drug manufacturing.

Find out how Automated Industrial Robotics Inc.’s KAON Automation acquisition strengthens aseptic filling and pharmaceutical manufacturing automation.

The European Commission’s recent approval of €47 million in German state aid for Vetter Pharma’s new aseptic filling facility in Saarlouis marks more than a regional win. It signals a structural shift in how Europe views contract manufacturing organizations, or CDMOs—not merely as outsourcing vendors, but as core pillars of supply chain resilience, regional economic […]